✦ LIBER ✦

Dipeptyl peptidase – 4 inhibitors in type 2 diabetes: Cardiovascular risk reduction?

✍ Scribed by Zarowitz, Barbara J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular safety of the dipetidyl p

✍ White, W. B.; Pratley, R.; Fleck, P.; Munsaka, M.; Hisada, M.; Wilson, C.; Menon 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Cardiovascular risk factor reduction eff

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Dipeptidyl peptidase 4 (DPP-4) inhibitor

✍ Crepaldi, G.; Carruba, M.; Comaschi, M.; Prato, S.; Frajese, G.; Paolisso, G. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 101 KB

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Dr. Joshua J. Neumiller; Dr. Lindy Wood; Mr. R. Keith Campbell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Potential cardiovascular effects of dipe

✍ Mosenzon, O.; Raz, I. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 145 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB